Mullen G B, DeCory T R, Allen S D, Mitchell J T, St Georgiev V
Department of Organic Chemistry, Pennwalt Corporation, Rochester, N.Y.
Chemotherapy. 1988;34(6):444-7. doi: 10.1159/000238606.
The in vitro antifungal activity of a series of novel 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyli soxazolidines and related compounds against Trichophyton rubrum, Aspergillus fumigatus and Candida albicans was studied. The screening was performed in solid agar cultures and some structure-activity relationships involving the C-5-substitution pattern are discussed.